115 related articles for article (PubMed ID: 8004582)
1. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer.
Sukoh N; Abe S; Ogura S; Isobe H; Takekawa H; Inoue K; Kawakami Y
Cancer; 1994 Jul; 74(1):46-51. PubMed ID: 8004582
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Werle B; Jülke B; Lah T; Spiess E; Ebert W
Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961
[TBL] [Abstract][Full Text] [Related]
3. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
Mori M; Kohli A; Baker SP; Savas L; Fraire AE
Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
7. [Clinical indicators of malignancy of lung cancer].
Abe S; Sukoh N; Ogura S; Isobe H
Hokkaido Igaku Zasshi; 1994 May; 69(3):391-5. PubMed ID: 7927167
[TBL] [Abstract][Full Text] [Related]
8. Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer.
Kayser K; Richter N; Hufnagl P; Kayser G; Kos J; Werle B
Anticancer Res; 2003; 23(3C):2767-72. PubMed ID: 12926111
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Fujise N; Nanashim A; Taniguchi Y; Matsuo S; Hatano K; Matsumoto Y; Tagawa Y; Ayabe H
Lung Cancer; 2000 Jan; 27(1):19-26. PubMed ID: 10672780
[TBL] [Abstract][Full Text] [Related]
10. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression.
Ozeki Y; Takishima K; Takagi K; Aida S; Tamai S; Mamiya G; Ogata T
Jpn J Cancer Res; 1993 Sep; 84(9):972-5. PubMed ID: 8407565
[TBL] [Abstract][Full Text] [Related]
12. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
Inoue T; Ishida T; Sugio K; Sugimachi K
Cancer Res; 1994 Dec; 54(23):6133-6. PubMed ID: 7954459
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
15. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
16. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]